4/22
07:50 am
lxeo
Lexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy [Yahoo! Finance]
Medium
Report
Lexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy [Yahoo! Finance]
4/22
07:30 am
lxeo
Lexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy
Medium
Report
Lexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy
4/16
07:34 am
lxeo
Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich's Ataxia Cardiomyopathy [Yahoo! Finance]
Medium
Report
Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich's Ataxia Cardiomyopathy [Yahoo! Finance]
4/16
07:30 am
lxeo
Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich’s Ataxia Cardiomyopathy
High
Report
Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich’s Ataxia Cardiomyopathy
4/9
05:49 pm
lxeo
Lexeo: Targeted Alzheimer's Disease Treatment Approach Might Pay Off [Seeking Alpha]
Medium
Report
Lexeo: Targeted Alzheimer's Disease Treatment Approach Might Pay Off [Seeking Alpha]
3/13
04:22 pm
lxeo
Lexeo Therapeutics Announces Closing of Oversubscribed $95.0 Million Equity Financing
Medium
Report
Lexeo Therapeutics Announces Closing of Oversubscribed $95.0 Million Equity Financing
3/11
08:16 am
lxeo
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights [Yahoo! Finance]
High
Report
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights [Yahoo! Finance]
3/11
07:42 am
lxeo
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
High
Report
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
3/11
07:41 am
lxeo
Lexeo Therapeutics Announces Oversubscribed $95.0 Million Equity Financing [Yahoo! Finance]
High
Report
Lexeo Therapeutics Announces Oversubscribed $95.0 Million Equity Financing [Yahoo! Finance]
3/11
07:30 am
lxeo
Lexeo Therapeutics Announces Oversubscribed $95.0 Million Equity Financing
Medium
Report
Lexeo Therapeutics Announces Oversubscribed $95.0 Million Equity Financing
2/5
07:00 am
lxeo
Lexeo Therapeutics Strengthens Clinical Development Leadership with New Executive Appointments
Medium
Report
Lexeo Therapeutics Strengthens Clinical Development Leadership with New Executive Appointments